newsfilter
← Latest News
PR Newswire·

Compugen to Participate in Multiple Virtual Investor Conferences in April 2025

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...